Cargando…
Major Histocompatibility Complex and Hematopoietic Stem Cell Transplantation: Beyond the Classical HLA Polymorphism
Allogeneic hematopoietic stem cell transplantation (HSCT) represents a curative treatment for many patients with hematological malignant or non-malignant disorders. Evaluation of potential donors for HSCT includes a rigorous assessment of the human leukocyte antigens (HLA) match status of family mem...
Autores principales: | Bertaina, Alice, Andreani, Marco |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5855843/ https://www.ncbi.nlm.nih.gov/pubmed/29470425 http://dx.doi.org/10.3390/ijms19020621 |
Ejemplares similares
-
The Major Histocompatibility Complex in Transplantation
por: Ayala García, Marco Antonio, et al.
Publicado: (2012) -
Genetic Association of Hematopoietic Stem Cell Transplantation Outcome beyond Histocompatibility Genes
por: Gam, Rihab, et al.
Publicado: (2017) -
Histocompatibility and Hematopoietic Transplantation in the Zebrafish
por: de Jong, Jill L. O., et al.
Publicado: (2012) -
“HLA-C: evolution, epigenetics, and pathological implications in the major histocompatibility complex”
por: Velastegui, Erick, et al.
Publicado: (2023) -
Role of major histocompatibility complex variation in graft-versus-host disease after hematopoietic cell transplantation
por: Petersdorf, Effie W.
Publicado: (2017)